Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-DRAK2 Polyclonal Antibody

😃Good
Catalog No. TMAB-05314

Anti-DRAK2 Polyclonal Antibody is a Rabbit antibody targeting DRAK2. Anti-DRAK2 Polyclonal Antibody can be used in IHC-P,IHC-Fr,ICC/IF,IF.

Anti-DRAK2 Polyclonal Antibody

Anti-DRAK2 Polyclonal Antibody

😃Good
Catalog No. TMAB-05314
Anti-DRAK2 Polyclonal Antibody is a Rabbit antibody targeting DRAK2. Anti-DRAK2 Polyclonal Antibody can be used in IHC-P,IHC-Fr,ICC/IF,IF.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
50 μL$2217-10 days7-10 days
100 μL$3747-10 days7-10 days
200 μL$5277-10 days7-10 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-DRAK2 Polyclonal Antibody is a Rabbit antibody targeting DRAK2. Anti-DRAK2 Polyclonal Antibody can be used in IHC-P,IHC-Fr,ICC/IF,IF.
Ig Type
IgG
Reactivity
Human,Rat (predicted:Mouse,Chicken,Dog,Pig,Cow,Horse,Rabbit,Sheep)
Application
Recommended Dose
IHC-P: 1:100-500; IHC-Fr: 1:100-500; ICC/IF: 1:100-500; IF: 1:100-500
Antibody Type
Polyclonal
Host SpeciesRabbit
Subcellular LocalizationNucleus. Cell membrane. Endoplasmic reticulum-Golgi intermediate compartment. Note=Colocalizes with STK17B at the plasma membrane.
Tissue SpecificityHighly expressed in placenta, lung, pancreas. Lower levels in heart, brain, liver, skeletal muscle and kidney.
ConstructionPolyclonal Antibody
PurificationProtein A purified
AppearanceLiquid
Formulation0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Concentration1mg/ml
Research BackgroundApoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 (for DAP kinase related apoptosis inducing protein kinases). DRAKs contain an N terminal kinase domain and a C terminal regulation domain. Overexpression of DRAK2 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK2 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues.
Antigen Details
Immunogen
KLH conjugated synthetic peptide: human DRAK2
Antigen Species
Human
Gene Name
STK17B
Gene ID
Protein Name
Serine/threonine-protein kinase 17B
Uniprot ID
Function
Acts as a positive regulator of apoptosis.
Chemical Properties
Molecular WeightTheoretical: 42 kDa.
Stability & Storage
Stability & StorageStore at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles.
TransportShipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Anti-DRAK2 Polyclonal Antibody | purchase Anti-DRAK2 Polyclonal Antibody | Anti-DRAK2 Polyclonal Antibody cost | order Anti-DRAK2 Polyclonal Antibody | Anti-DRAK2 Polyclonal Antibody molecular weight